Alteration of Neuroinflammation Detected by F-GE180 PET Imaging in Place-conditioned Rats with Morphine Withdrawal

Overview

Journal EJNMMI Res

Date 2021 Oct 12

PMID 34637020

Citations 2

Authors

Junpeng Li

Da Shao

Donglang Jiang

Qi Huang

Yihui Guan

Bin Lai

Jun Zhao

Fengchun Hua

Fang Xie

Affiliations

Soon will be listed here.

Abstract

Background: Accumulating evidence indicates that neuroinflammation (NI) significantly contributes to drug addiction, but the conversion of NI after drug withdrawal is not clear. Here, we conducted F-flutriciclamide (GE180) positron emission tomography (PET) imaging to investigate the conversion of NI during drug withdrawal and conditioning-induced aversion by measuring the change in microglial activation with F-GE180.

Methods: Twelve male adult Sprague-Dawley rats were subjected to morphine withdrawal by the administration of naloxone, and six of them were used to model conditioned place aversion (CPA). F-GE180 PET imaging was performed for 11 rats on the last day of the morphine treatment phase and for 10 rats on the response assessment phase of the behavior conditioning procedure. A F-GE180 template was established for spatial normalization of each individual image, and the differential F-GE180 uptakes between the drug withdrawal (DW) group and the drug addiction (DA) group, the CPA group and the DA group, and the CPA group and the DW group were compared by a voxel-wise two-sample t test using SPM8.

Results: Both the DW group and the CPA group spent less time in the conditioning cage during the post-test phase compared with the pretest phase, but only the difference in the CPA group was significant (63.2 ± 34.6 vs. - 159.53 ± 22.02, P < 0.005). Compared with the DA group, the uptake of F-GE180 increased mainly in the hippocampus, visual cortex, thalamus and midbrain regions and decreased mainly in the sensory-related cortices after the administration of naloxone in both the DW and CPA groups. Increased F-GE180 uptake was only observed in the mesolimbic regions after conditioned aversion compared with the DW group.

Conclusion: In morphine-dependent rats, Neuroinflammation (NI) became more severe in the addiction-involved brain regions but remitted in the sensory-related brain regions after the administration of naloxone, and this NI induced by withdrawal was further aggravated after conditioned aversion formation thus may help to consolidate the withdrawal memory.

Citing Articles

Amelioration of morphine withdrawal syndrome by systemic and intranasal administration of mesenchymal stem cell-derived secretome in preclinical models of morphine dependence.

Quezada M, Ponce C, Berrios-Carcamo P, Santapau D, Gallardo J, De Gregorio C CNS Neurosci Ther. 2023; 30(4):e14517.

PMID: 37927136 PMC: 11017443. DOI: 10.1111/cns.14517.

Neuroimaging of opioid exposure: a review of preclinical animal models to inform addiction research.

Kamens H, Cramer S, Hanley R, Chase S, Wickenheisser A, Horton W Psychopharmacology (Berl). 2023; 240(12):2459-2482.

PMID: 37857897 DOI: 10.1007/s00213-023-06477-6.

References

Papadopoulos V, Baraldi M, Guilarte T, Knudsen T, Lacapere J, Lindemann P . Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006; 27(8):402-9. DOI: 10.1016/j.tips.2006.06.005. View

Xie F, Xi Y, Pascual J, Muzik O, Peng F . Age-dependent changes of cerebral copper metabolism in Atp7b knockout mouse model of Wilson's disease by [Cu]CuCl-PET/CT. Metab Brain Dis. 2017; 32(3):717-726. PMC: 5573586. DOI: 10.1007/s11011-017-9956-9. View

Stinus L, Cador M, Zorrilla E, Koob G . Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology. 2004; 30(1):90-8. DOI: 10.1038/sj.npp.1300487. View

Chao O, de Souza Silva M, Yang Y, Huston J . The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties. Neurosci Biobehav Rev. 2020; 113:373-407. PMC: 7302494. DOI: 10.1016/j.neubiorev.2020.04.007. View

Jiang X, Ni Y, Liu T, Zhang M, Ren H, Xu G . Inhibition of LPS-induced retinal microglia activation by naloxone does not prevent photoreceptor death. Inflammation. 2012; 36(1):42-52. DOI: 10.1007/s10753-012-9518-6. View

James M, Belichenko N, Shuhendler A, Hoehne A, Andrews L, Condon C . [F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease. Theranostics. 2017; 7(6):1422-1436. PMC: 5436503. DOI: 10.7150/thno.17666. View

Jiang D, Lu X, Li Z, Rydberg N, Zuo C, Peng F . Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent. Front Neurosci. 2019; 12:1052. PMC: 6340981. DOI: 10.3389/fnins.2018.01052. View

Millan E, Ong Z, McNally G . Paraventricular thalamus: Gateway to feeding, appetitive motivation, and drug addiction. Prog Brain Res. 2017; 235:113-137. DOI: 10.1016/bs.pbr.2017.07.006. View

Auvity S, Saba W, Goutal S, Leroy C, Buvat I, Cayla J . Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates. Int J Neuropsychopharmacol. 2016; 20(1):67-71. PMC: 5737475. DOI: 10.1093/ijnp/pyw077. View

10.

Boutin H, Prenant C, Maroy R, Galea J, Greenhalgh A, Smigova A . [18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats. PLoS One. 2013; 8(2):e56441. PMC: 3572061. DOI: 10.1371/journal.pone.0056441. View

11.

Due D, Huettel S, Hall W, Rubin D . Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry. 2002; 159(6):954-60. DOI: 10.1176/appi.ajp.159.6.954. View

12.

Moeller S, Tomasi D, Woicik P, Maloney T, Alia-Klein N, Honorio J . Enhanced midbrain response at 6-month follow-up in cocaine addiction, association with reduced drug-related choice. Addict Biol. 2012; 17(6):1013-25. PMC: 3394885. DOI: 10.1111/j.1369-1600.2012.00440.x. View

13.

Caggiano V, Leiras R, Goni-Erro H, Masini D, Bellardita C, Bouvier J . Midbrain circuits that set locomotor speed and gait selection. Nature. 2018; 553(7689):455-460. PMC: 5937258. DOI: 10.1038/nature25448. View

14.

Boutin H, Murray K, Pradillo J, Maroy R, Smigova A, Gerhard A . 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. Eur J Nucl Med Mol Imaging. 2014; 42(3):503-11. DOI: 10.1007/s00259-014-2939-8. View

15.

Burma N, Bonin R, Leduc-Pessah H, Baimel C, Cairncross Z, Mousseau M . Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents. Nat Med. 2017; 23(3):355-360. DOI: 10.1038/nm.4281. View

16.

Huang A, Mitchell J, Haber S, Alia-Klein N, Goldstein R . The thalamus in drug addiction: from rodents to humans. Philos Trans R Soc Lond B Biol Sci. 2018; 373(1742). PMC: 5790826. DOI: 10.1098/rstb.2017.0028. View

17.

Sridharan S, Lepelletier F, Trigg W, Banister S, Reekie T, Kassiou M . Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats. Mol Imaging Biol. 2016; 19(1):77-89. PMC: 5209405. DOI: 10.1007/s11307-016-0984-3. View

18.

Cooper Z, Johnson K, Pavlicova M, Glass A, Vosburg S, Sullivan M . The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addict Biol. 2015; 21(4):895-903. PMC: 4644513. DOI: 10.1111/adb.12261. View

19.

Hutchinson M, Lewis S, Coats B, Skyba D, Crysdale N, Berkelhammer D . Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun. 2008; 23(2):240-50. PMC: 2662518. DOI: 10.1016/j.bbi.2008.09.012. View

20.

Shao D, Fu Y, Ma Q, Chen M, Cui D, Song J . Key determinants for morphine withdrawal conditioned context-induced increase in Arc expression in anterior cingulate cortex and withdrawal memory retrieval. Exp Neurol. 2018; 311:234-246. DOI: 10.1016/j.expneurol.2018.10.009. View